{"id":"NCT00011986","sponsor":"Gynecologic Oncology Group","briefTitle":"Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer","officialTitle":"A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-01","primaryCompletion":"2010-03","completion":"2013-01-28","firstPosted":"2003-01-27","resultsPosted":"2016-04-19","lastUpdate":"2019-04-16"},"enrollment":4312,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Primary Peritoneal Carcinoma","Stage III Ovarian Cancer","Stage IV Ovarian Cancer"],"interventions":[{"type":"DRUG","name":"Paclitaxel","otherNames":["Anzatax","TAX"]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Gemcitabine Hydrochloride","otherNames":["dFdC","dFdCyd"]},{"type":"DRUG","name":"Pegylated Liposomal Doxorubicin Hydrochloride","otherNames":["doxorubicin HCl liposome","TLC D-99"]},{"type":"DRUG","name":"Topotecan Hydrochloride","otherNames":["Hycamtin","SKF S-104864-A","TOPO"]},{"type":"PROCEDURE","name":"Therapeutic Conventional Surgery","otherNames":[]}],"arms":[{"label":"Arm I","type":"ACTIVE_COMPARATOR"},{"label":"Arm II","type":"EXPERIMENTAL"},{"label":"Arm III","type":"EXPERIMENTAL"},{"label":"Arm IV","type":"EXPERIMENTAL"},{"label":"Arm V","type":"EXPERIMENTAL"}],"summary":"Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is most effective in treating ovarian epithelial cancer and peritoneal cancer. Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have stage III or stage IV ovarian cancer or primary peritoneal cancer.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Up to 9 years","effectByArm":[{"arm":"Carbo/Taxol","deltaMin":0.35,"sd":null},{"arm":"Carbo/Taxol/Gemcitabine","deltaMin":0.34,"sd":null},{"arm":"Carbo/Taxol/Doxil","deltaMin":0.39,"sd":null},{"arm":"Carbo/Topotecan - Carbo/Taxol","deltaMin":0.34,"sd":null},{"arm":"Carbo/Gemcitabine - Carbo/Taxol","deltaMin":0.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":29,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["37229879","37148580","30633128","24779680","23969788"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":86,"n":777},"commonTop":["Neutropenia","Leukopenia","Anemia","Thrombocytopenia","Gastrointestinal"]}}